The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review.
Saved in:
| Title: | The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review. |
|---|---|
| Authors: | Park H; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Robinson J; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Flanagan C; King's College Hospital, London, UK., Pawlyn C; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital NHS Foundation Trust, London, UK., Jackson G; Department of Hematology, University of Newcastle, Newcastle, UK., Jones JR; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.; King's College Hospital, London, UK.; East Sussex Healthcare NHS Trust, Kent, UK. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2026 Jan; Vol. 67 (1), pp. 7-16. Date of Electronic Publication: 2025 Sep 29. |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2025.2560085 |
